KURUME UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1930-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.kurume-u.ac.jp
Clinical Trials
58
Active:0
Completed:47
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:3
Phase 2:3
+3 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (56 trials with phase data)• Click on a phase to view related trials
Not Applicable
43 (76.8%)Phase 4
4 (7.1%)Phase 1
3 (5.4%)Phase 2
3 (5.4%)Phase 3
2 (3.6%)Early Phase 1
1 (1.8%)An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Transitioning to Lemborexant in Japanese Subjects With Insomnia
- First Posted Date
- 2021-02-08
- Last Posted Date
- 2023-03-15
- Lead Sponsor
- Kurume University
- Target Recruit Count
- 97
- Registration Number
- NCT04742699
- Locations
- 🇯🇵
YOU ARIYOSHI Sleep Clinic, Kitakyushu, Fukuoka, Japan
🇯🇵Kurume University Hospital, Kurume, Fukuoka, Japan
🇯🇵Hirota Clinic, Kurume, Fukuoka, Japan
Efficacy of Olmesartan on Cerebral Glucose Metabolism, Vascular Inflammation and Adipose Tissue
Phase 4
- Conditions
- Efficacy of Olmesartan on Cerebral Glucose Metabolism in Essential Hypertension
- Interventions
- First Posted Date
- 2016-12-19
- Last Posted Date
- 2016-12-20
- Lead Sponsor
- Kurume University
- Target Recruit Count
- 100
- Registration Number
- NCT02996916
- Locations
- 🇯🇵
Kurume University Hospital, Kurume, Japan
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors
Phase 4
- Conditions
- Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
- Interventions
- First Posted Date
- 2015-08-19
- Last Posted Date
- 2015-08-19
- Lead Sponsor
- Kurume University
- Target Recruit Count
- 100
- Registration Number
- NCT02528019
- Locations
- 🇯🇵
Kurume University Hospital, Kurume city, Japan
Effects of Montelukast on Airway Regulatory T Cells in Asthma
- First Posted Date
- 2013-09-27
- Last Posted Date
- 2013-09-27
- Lead Sponsor
- Kurume University
- Target Recruit Count
- 15
- Registration Number
- NCT01951898
- Locations
- 🇯🇵
Kurume University School of Medicine, Kurume, Japan
Pioglitazone Decreases Visceral Fat Metabolism
Not Applicable
- Conditions
- To Evaluate the Effect of Pioglitazone on Glucose Metabolism of Fat Tissue by Using FDG-PET/CT Imaging
- Interventions
- First Posted Date
- 2013-03-27
- Last Posted Date
- 2013-03-27
- Lead Sponsor
- Kurume University
- Target Recruit Count
- 60
- Registration Number
- NCT01819402
- Locations
- 🇯🇵
Kurume University, Kurume, Japan
- Prev
- 1
- 2
- 3
- Next
News
No news found